NYSE:HAEMedical Equipment
Haemonetics Wins FDA Nod For Persona PLUS Plasma Growth Opportunity
Haemonetics (NYSE:HAE) has received FDA 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS technology.
The clearance covers the company's next generation plasma collection platform, Persona PLUS, which is designed to improve plasma collection per donation.
This regulatory milestone marks an important step in advancing Haemonetics' plasma collection offerings within the U.S. market.
Haemonetics focuses on blood and plasma collection technologies, so any regulatory...